{
  "paper_metadata": {
    "pmid": "25136594",
    "title": "Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6841+79delTTAA",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 101,
        "demographics": "not specified",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 14,
        "affected_count": 14,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "breast and ovarian cancer",
          "evidence_sentence": "In total 14 GS Junior runs, we identified 14 patients with deleterious mutations of which 7 are frameshift mutations, 4 are nonsense, 2 are missense, and 1 is an in frame deletion that affects splicing."
        }
      ],
      "functional_data": {
        "summary": "The deletion was detected both in heterozygosity and homozygosity.",
        "assays": [
          "Sanger sequencing"
        ]
      },
      "segregation_data": "The pathogenic variants were all detected in heterozygosity.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is located in intron 11.",
      "key_quotes": [
        "Deletion of c.6841+79delTTAA in intron 11 of the BRCA2 gene was detected both in heterozygosity and homozygosity."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4030del6insC",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 101,
        "demographics": "not specified",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 14,
        "affected_count": 14,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "breast and ovarian cancer",
          "evidence_sentence": "Sanger sequencing identified one deletion, one insertion, and a combined InDel (c.4030del6insC, c.5189dupA, and c.5722_5723delCT in the BRCA2 gene)."
        }
      ],
      "functional_data": {
        "summary": "The deletion was confirmed by Sanger sequencing.",
        "assays": [
          "Sanger sequencing"
        ]
      },
      "segregation_data": "The pathogenic variants were all detected in heterozygosity.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a combined InDel.",
      "key_quotes": [
        "Sanger sequencing identified one deletion, one insertion, and a combined InDel (c.4030del6insC, c.5189dupA, and c.5722_5723delCT in the BRCA2 gene)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5189dupA",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 101,
        "demographics": "not specified",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 14,
        "affected_count": 14,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "breast and ovarian cancer",
          "evidence_sentence": "Sanger sequencing identified one deletion, one insertion, and a combined InDel (c.4030del6insC, c.5189dupA, and c.5722_5723delCT in the BRCA2 gene)."
        }
      ],
      "functional_data": {
        "summary": "The insertion was confirmed by Sanger sequencing.",
        "assays": [
          "Sanger sequencing"
        ]
      },
      "segregation_data": "The pathogenic variants were all detected in heterozygosity.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a combined InDel.",
      "key_quotes": [
        "Sanger sequencing identified one deletion, one insertion, and a combined InDel (c.4030del6insC, c.5189dupA, and c.5722_5723delCT in the BRCA2 gene)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5722_5723delCT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 101,
        "demographics": "not specified",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 14,
        "affected_count": 14,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "breast and ovarian cancer",
          "evidence_sentence": "Sanger sequencing identified one deletion, one insertion, and a combined InDel (c.4030del6insC, c.5189dupA, and c.5722_5723delCT in the BRCA2 gene)."
        }
      ],
      "functional_data": {
        "summary": "The deletion was confirmed by Sanger sequencing.",
        "assays": [
          "Sanger sequencing"
        ]
      },
      "segregation_data": "The pathogenic variants were all detected in heterozygosity.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is part of a combined InDel.",
      "key_quotes": [
        "Sanger sequencing identified one deletion, one insertion, and a combined InDel (c.4030del6insC, c.5189dupA, and c.5722_5723delCT in the BRCA2 gene)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8009delC",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "novel",
      "patients": {
        "count": 101,
        "demographics": "not specified",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 14,
        "affected_count": 14,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "breast and ovarian cancer",
          "evidence_sentence": "We have identified 5 novel mutations in our cohort. Mutation c.2900_2901dupCT in the BRCA1 gene and mutations c.4030del6insC, c.5189dupA, c.8009delC, and c.9274delT in the BRCA2 gene are mutations not described previously."
        }
      ],
      "functional_data": {
        "summary": "The deletion is novel and has not been described previously.",
        "assays": [
          "Sanger sequencing"
        ]
      },
      "segregation_data": "The pathogenic variants were all detected in heterozygosity.",
      "population_frequency": null,
      "evidence_level": "medium",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is novel.",
      "key_quotes": [
        "We have identified 5 novel mutations in our cohort. Mutation c.2900_2901dupCT in the BRCA1 gene and mutations c.4030del6insC, c.5189dupA, c.8009delC, and c.9274delT in the BRCA2 gene are mutations not described previously."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.9274delT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "novel",
      "patients": {
        "count": 101,
        "demographics": "not specified",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 14,
        "affected_count": 14,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "breast and ovarian cancer",
          "evidence_sentence": "We have identified 5 novel mutations in our cohort. Mutation c.2900_2901dupCT in the BRCA1 gene and mutations c.4030del6insC, c.5189dupA, c.8009delC, and c.9274delT in the BRCA2 gene are mutations not described previously."
        }
      ],
      "functional_data": {
        "summary": "The deletion is novel and has not been described previously.",
        "assays": [
          "Sanger sequencing"
        ]
      },
      "segregation_data": "The pathogenic variants were all detected in heterozygosity.",
      "population_frequency": null,
      "evidence_level": "medium",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is novel.",
      "key_quotes": [
        "We have identified 5 novel mutations in our cohort. Mutation c.2900_2901dupCT in the BRCA1 gene and mutations c.4030del6insC, c.5189dupA, c.8009delC, and c.9274delT in the BRCA2 gene are mutations not described previously."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 6,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}